Immunicon
Immunicon Corporation (NASDAQ IMMC) was a Huntingdon Valley, Pennsylvania biotechnology company that pioneered immunomagnetic cell-selection technology for isolating and characterizing rare circulating tumor cells (CTCs) from blood. It developed the CellSearch and CellTracks diagnostic platforms, licensed to Veridex, LLC (a Johnson & Johnson company) for oncology use. Immunicon filed for Chapter 11 bankruptcy in 2008 and was acquired by Veridex/Johnson & Johnson; the CellSearch platform later passed to Menarini Silicon Biosystems. The company was backed by Canaan Partners and publishes no public API or developer surface.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Immunicon is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Immunicon scores 5.7/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
Immunicon is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/immunicon · machine-readable index on apis.io